Consulting: Longevity bioscience
Drug discovery for longevity interventions
From early 2019 to mid-2021, I built and managed a longevity bioscience research portfolio at the University of Oxford. A high level overview “Hedging bets on healthier aging” touches on longevity research, drug discovery, and academic project/portfolio management. Beyond what’s covered in that post, I gained significant knowledge and expertise specific to clinical trial design for longevity interventions.